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Background: To evaluate the frequency of positive coronary arteries calcium (CAC) scores in a unique population
of asymptomatic first degree relatives (FDRs) of patients with angiographically confirmed early onset of coronary
artery disease (CAD) and to assess their association with carotid ultrasound findings and other cardiovascular
risk factors.
Method and results: We scanned, using 64-slice multi-detector computed tomography, 57 asymptomatic FDRs
(47 ± 9 years old; 44% male, 56% female), out of the 111 FDRs previously phenotyped for cardiovascular (CV) risk
factors. The controls were 616 individuals (57 ± 10 years old; 76% male, 24% female) with no family history of
cardiovascular disease, chest pain or diabetes selected out of the 3500 subjects scanned between 2002 and 2007.
FDRs had higher risk of abnormal CAC scores compared to controls; odds ratio (OR) for the 75th percentile was
1.96 (95% CI 1.04 – 3.67, p< 0.05).
Conclusion: The frequency of abnormal CAC scores is two-fold higher in asymptomatic FDRs than in controls.
CAC scan provides additional information on CV risk assessment in asymptomatic FDRs, particularly for those in the
intermediate risk category.
Clinical trial registration: NCT00387595Background
Validated family history of premature coronary artery
disease (CAD) in men <55 and women <65 years of age
is an independent risk factor for cardiovascular disease
(CVD) [1-5]. Although Framingham risk score [6] does
not include family history, European SCORE risk tools
[7] and current Canadian and U.S. guidelines for man-
agement of dyslipidemia [8,9] stipulate up to a two-fold
increase in the risk of developing CVD in the presence
of positive family history of CAD.
Calcium deposits in the coronary arteries are consid-
ered a marker of atherosclerotic burden [10]. CAC
assessed by computed tomography (CT) is a strong pre-
dictor of cardiovascular (Relative Risk [RR] = 9.6) and* Correspondence: jifr@interchange.ubc.ca
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distribution, and reproduction in any mediumcoronary events (RR = 11.1), non-fatal myocardial infarc-
tion (RR = 9.2), and an independent predictor of all-
cause mortality [11-13].
Coronary artery calcification (CAC) score is recog-
nized as a highly sensitive method to measure subclinical
atherosclerosis in asymptomatic patients [11,12,14-16].
CAC scans provide incremental independent prognostic
value above the Framingham risk factors in young
asymptomatic men [16]. The benefits of defining a CAC
scoring threshold to assess risk in asymptomatic indivi-
duals with confirmed family history of early cardiovascu-
lar disease remains uncertain.
We compared, using a prospective case – control de-
sign, the frequency of positive CAC findings, assessed by
multi-detector computed tomography (MDCT), in
asymptomatic individuals with and without family history
of early CAD. In addition we compared CAC findings
with carotid ultrasound indexes of early atherosclerosis
(combined measurements of diffuse carotid intima-
media thickening and focal plaques), as well as othertral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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the first degree relatives (FDRs) cohort [17].
Methods
The study protocol was approved by the joined institu-
tional review board of St. Paul Hospital and University
of British Columbia; all participants gave their informed
consent.
Study population
First degree relatives (FDRs) of patients with early onset
CAD (men <50 years, women <60 years) confirmed
angiographically as part of their clinical care were identi-
fied as the study cohort. The risk factor profiles and ca-
rotid ultrasound findings of the FDRs had been
documented previously [17]. In brief, classical (age, gen-
der, smoking status, blood pressure, lipid profile, apoli-
poprotein and fasting glucose) as well as newly
recognized risk factors (lipoprotein(a), high sensitivity C-
reactive protein and total homocysteine) had been mea-
sured. Carotid B-mode ultrasound was carried out in
111 FDRs with carotid intima-media thickness, plaque
size and number recorded. Previously validated carotid
ultrasound indexes, combining intima-media thickness
and plaque measurements, were used to measure burden
of atherosclerosis in both the carotid arteries of asymp-
tomatic subjects [18,19]. Total plaque area (TPA) is the
product of length and thickness of each focal lesion(s);
total area (TA) is the sum of plaque areas and the area
of diffuse, intima-media thickness measured, in the far
wall of the common carotid artery; average total thick-
ness (ATT) is the total area divided by the total length
of carotid wall measured. The intima-media thickness
was an average of measurements taken over a 10-mm,
plaque free, arterial wall segment of left and right com-
mon carotid artery, within 2-cm proximity from the
bulb. Millimeters and square millimeters were used to
express measurements of distance and areas respectively.
Subjects who had a chest X-ray or CT in the previous
12 months, pregnant women or women who might have
been pregnant were excluded from the study. Of the ini-
tial 111 subjects, a total of 57 consenting FDRs (2 par-
ents, 18 children and 37 siblings), 25 years of age and
older, without clinical CAD, diabetes or chest pain,
underwent CAC scoring by 64-slice MDCT scan within
one year of the carotid ultrasound and within a year and
a half of the first contact.
Framingham risk scores were calculated and subjects
classified at low, intermediate or high risk of having CV
events based on current guidelines [9].
Control population
Control subjects were drawn from 3500 asymptomatic
individuals who underwent CAC scoring betweenJanuary 2002 and May 2007 in the same medical im-
aging center. Exclusion criteria included presence of
CAD, prior assessment of CAC (no follow-up examina-
tions were included in the control group) or age under
40. Subjects were either self-referred, referred to the
clinic by a physician or were executives having the scan
done as part of their health plan. All subjects were
required to submit a pre-scan questionnaire. Subjects
reporting a history of chest pain, or not indicating an
absence of chest pain, were excluded to ensure an asymp-
tomatic cohort. To match the criteria applied to the study
subjects we excluded control subjects that reported dia-
betes as a current health problem.
A total of 616 subjects (57.2 ± 10 years old; 76% men,
24% women) served as the control group. This repre-
sents 20% of the total number of subjects scanned, who
stated, on the pre-scan questionnaire no family history
of cardiovascular disease. Smoking status was confirmed
in 416 subjects. At the time of the scan 43 were smokers
(defined as currently smoking or gave up in the last
month); extrapolating the results, smokers represent
10% of the control group.
64-Slice multi detector computed tomography
All FDRs were scanned with a 64-slice MDCT (Aquilion
64, Toshiba America Medical Systems, Tustin, California)
while subjects from the control group were scanned with
either 64- or a 8-slice MDCT (Lightspeed Ultra, GE, Mil-
waukee, Wisconsin). The participants were told to ab-
stain from caffeine the morning of the day of the
scan. No pharmacological intervention or oxygen was
administered prior to the scan to reduce the heart
rate, though 75 beats per minute was effectively used
as the cut-off limit. The scan extended from the ascend-
ing aorta 12 cm inferiorly towards the cardiac apex with a
slice collimation of 64 x 0.5 mm (100 mA, 120KVp, aver-
age effective dose 0.9-1.1 mSv) for the Aquilion and 8 x
2.5 mm (230 mA, 120KVp, average effective dose 1 mSv)
for the Lightspeed Ultra. Breath-hold image acquisition
used prospective ECG gating (triggered at 50% of cardiac
cycle) to minimize radiation dose [20].
CAC scoring was performed by two physicians, in
consensus, on an offline computer station using the
VScoreTM with AutoGateTM (Vitrea, Vital Image
Software package; version 3.9). The radiologists were not
blinded when reading FDRs scans. Under radiologist
control each coronary artery (left main, left anterior
descending, left circumflex, right and posterior descend-
ing artery) was selected; Agatston and Volume scores
were calculated by the software package. In calculating
the Agatston score [21] plaques with greater attenuation
were weighted higher (pixels 0.26-0.35 mm2; >130
Hounsfield units), while volumetric score using isomet-
ric interpolation eliminates partial volume effect [22].
Table 1 Characteristics of the first degree relatives
(FDRs) cohort *
n 57
Age 47.3 ± 8.9
BMI 27.5 ± 4.5
Waist circumference (cm) 90.3 ± 15.2
Systolic BP (mm Hg) 117.5 ± 17.4
Diastolic BP (mm Hg) 74.9 ± 14.0
Fasting glucose (mmol/L) 4.92 ± 0.8
Total cholesterol (mmol/L) 5.43 ± 1.1
Triglycerides (mmol/L) 1.33 ± 0.8
LDL-C (mmol/L) 3.40 ± 1.0
HDL-C (mmol/L) 1.42 ± 0.43
TC/HDL-C 4.15 ± 1.48
Lp(a) (mg/L) 153 (43–467)
Total homocysteine (mg/L) 9.6 (8.8 - 11.0)
hs-CRP (mg/L) 0.9 (0.7 - 3.25)
Apo-AI (g/L) 1.54 ± 0.31
Apo-B100 (g/L) 1.04 ± 0.29
Smoking (n,%) 8 (14%)
Framingham risk score (%) 1% (1% – 5%)
64-MDCT scores
Total Agatston score 0 (0–41.5)
Total Volumetric score 0 (0–50.5)
Carotid Ultrasound Indexes
Average IMT (mm) 0.67 (0.62 - 0.73)
Total plaque area (mm2) 5.59 (0–21.34)
Average total thickness (mm) 0.77 (0.67 - 1.00)
Total area (mm2) 19.0 (13.45 - 35.44)
Plaque No (n) 1 (0–3)
* data is presented as mean ± SD, except for: homocysteine, hs-CRP, Lp(a), FRS
and the imaging indexes were median and inter-quartile range was used.
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herein are the sum of partial scores obtained for the five
coronary artery readings.
Statistical analysis
Descriptive statistics for the study cohorts were pre-
sented as mean and standard deviation for all variables
except total homocysteine, lipoprotein(a), high sensitivity
C-reactive protein, carotid ultrasound measurements
and CAC scores for which median and interquartile
range were used. To test for the difference between
means, Mann–Whitney rank test, which assumes inde-
pendence of the two groups, was used. Fisher’s test and/
or Chi-square were used to test for differences in dichot-
omous variables. Two tail tests and 95% confidence
intervals were used for all analyses. The strength of cor-
relation between the CAC (total Agatston and total Vol-
ume) score, other known risk factors and carotid
ultrasound indexes in the FDRs was assessed by univari-
ate analysis and Spearman’s rank correlation test. To de-
termine whether family history of premature CAD is
predictive of higher CAC scores after adjusting for age
and gender we used a multivariate linear regression ana-
lysis. To determine if family history of early CAD
increases the likelihood of positive findings at CAC scan
we employed Chi-square analysis. We defined positive
CAC scan findings as values over 75th percentile for the
appropriate age and gender [23,24]. The same 75th per-
centile, age and gender adjusted, cut-off values were
used to define positive carotid ultrasound findings [17].
To assess the agreement between the identification of
the disease based on CIMT and CAC scores we
employed the kappa measure of agreement [25].
Odds ratios with 95% confidence intervals were calcu-
lated, using a log-linear general model, to determine the
odds of positive CAC findings in FDRs compared to
controls. A p-value< 0.05 was considered statistically
significant. All statistical analyses were performed using
SPSS 12.0 (SPSS Inc., Chicago, IL, USA) software
package.
Results
Clinical and biochemical characteristics of the cohorts
The FDRs were predominantly of European (48 out of
57) with only 6 of South-Asian, 2 of Chinese and one of
Aboriginal background. There was a significant differ-
ence in the gender distribution between the study group
(56% women, 44% men) and the control group (24%
women, 76% men). FDRs group (47.3 ± 8.9 years old)
was 10 years younger than the control group
(57.2 ± 10 years, p< 0.001). The slightly higher incidence
of smoking in FDRs (14%) compared to controls (10%)
was not statistically significant. There was a higher inci-
dence of CAC scores above the 75th and 90thpercentile, age and gender adjusted values, in FDRs
compared to controls (26.3% vs. 15.3% and 12.3% vs.
6.7%, respectively). A CAC score of 0 was recorded in
64.9% of the FDRs and 50.1% of the controls. Table 1
lists the biochemical and anthropometrical characteris-
tics of the FDRs cohort (not available for controls).
Correlations strength and likelihood of findings
The relationship between the extent of coronary calcifi-
cation and the assessed risk factors including carotid
ultrasound findings are summarized in Table 2. All
carotid ultrasound measurements had a higher correl-
ation with CAC scores than with any other risk factor
including the Framingham risk score. Homocysteine,
lipoprotein-(a) and high sensitivity C-reactive protein cor-
relations with CAC scores were not statistically signifi-
cant. In FDRs, kappa analysis of agreement showed
number of plaques (kappa = 0.324, p< 0.05) and average
total thickness (kappa = 0.226, p< 0.01), but not intima-
Table 2 Correlations of total Agatston and total volume
scores with risk factors and carotid ultrasound findings in
FDRs
Total Agatston Total Volume
rho* p rho* p
n= 57
Age 0.425 0.001 0.421 0.001
Diastolic BP 0.267 0.045 0.267 0.045
Framingham risk score 0.279 0.036 0.280 0.035
fasting Glucose 0.298 0.017 0.283 0.024
Total Cholesterol/HDL-C 0.256 0.041 0.259 0.039
Ultrasound indexes
AvgIMT 0.398 0.002 0.402 0.002
TPArea 0.458 0.000 0.460 0.000
AvgTThick 0.520 0.000 0.525 0.000
TArea 0.495 0.000 0.498 0.000
Plaque No 0.480 0.000 0.478 0.000
* rho - correlation coefficient (strength of correlation ranges form 0 to 1;
0 = no correlation); statistically significant p< 0.05; highly significant p< 0.005
(2-tailed). Note: Spearman's test measures the strength of correlations
between calcium scores (in the heading) and other risk factors (listed in the
first column) in the FDRs cohort; Carotid Ultrasound Indexes: AvgIMT= average
intima-media thickness; TPArea = total plaque area; AvgTThick = average total
thickness; TArea = total area; PlaqueNo=number of plaques.
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ment with the Agatston score findings above the 75th
percentile for the subjects age and sex.
The multivariate linear regression model, after adjust-
ment for age and sex, found that family history of CAD
was highly predictive of coronary calcium findings: total
Agaston score (β=0.102; p< 0.05) and total Volume score
(β=0.103; p< 0.05). To account for the CAC of 0 when
assessing for the difference between cohorts both Agatston
and Volume scores have been transformed in dichotomous
variables based on the age and sex adjusted 75th percentile
cut-off point. If the 75th percentile is used, FDRs are more
likely (χ2 (1, 673)= 12.78; p< 0.000) to have positive CAC
findings compared with controls (Table 3). Using the log-
linear model we show that FDRs have higher odds of hav-
ing positive CAC findings than controls; odds ratio (OR) is
1.959 (95%CI 1.044 - 3.673, p< 0.05). In sub-gender ana-
lysis, men with family history of early CAD had higher odds
OR 2.460 (95%CI 1.024 – 5.9, p< 0.05) than women ORTable 3 The predictive value of positive family history of
premature CAD for coronary artery calcium findings
Total Agatston Total Volume
Family history Beta Sig. Beta Sig.
Total † 0.102* 0.009 0.103* 0.011
Women & 0.185* 0.022 0.185* 0.022
Men & 0.053 0.227 0.051 0.267
* significant p< 0.05;† Multivariate linear regression model, age and gender
adjusted; & age adjusted only.1.806 (95%CI, 0.691 – 4.723, p=0.228) to have positive
CAC findings compared to controls.
CV risk assessment
The 10 year risk of a CV event based on the Framing-
ham risk score (FRS) [6] adjusted (two-fold) for the pres-
ence of family history of early CAD was low for 43,
moderate in 9 and high for 5 FDRs [9]. Positive carotid
ultrasound findings, IMT> 75th percentile or presence
of plaque, upgrades the CV risk category to high in 38
low risk and 7 intermediate risk FDRs, while CAC score
>75th percentile does the same for 8 low risk and 5
intermediate risk FDRs. CAC score of 0 downgrades 2
intermediate risk and 35 high risk FDRs to the low CV
risk category (see Figure 1). In summary, subclinical ath-
erosclerosis in either carotid or coronary arteries was
confirmed in 45 out of the 57 FDRs, while a CAC score
of 0 was found in 37 FDRs. The net result of using ca-
rotid ultrasound and CAC scoring, is reclassification of
all subjects from the intermediate risk group according
to Framingham risk factors into either high or low risk
groups.
Discussion
Our study demonstrates that in asymptomatic sub-
jects with a family history of early CAD the odds of
having CAC above the 75th percentile adjusted for
age and gender is twice as high as in controls. While
the result is similar to other studies it is important to
point out that our study identified FDR’s not by ques-
tionnaire or subject recall but via the angiographic
results of the proband, and also compares CAC find-
ings to ultrasound indexes that assess both IMT and
plaque burden [26]. The results indicate that these
odds are higher in men than in women with family
history of CAD when compared to controls. We also
demonstrate significant correlations between CAC
scan results and carotid ultrasound indexes of early
atherosclerosis, particularly those that combine mea-
sures of focal plaque burden with measures of diffuse
intima-media thickness measurements. Our study sug-
gests that CAC scoring, in particular when consider-
ing CAC scores of 0, may further improve risk
assessment in asymptomatic FDRs.
In the largest study to date that evaluated the impact
of various risk factors on CAC findings, Budoff et al.
showed that CAC can predict all cause mortality, inde-
pendent of family history of premature CAD [13]. In the
Framingham study cohort, a validated family history of
CAD correlated with a two fold increase in CAC find-
ings, when using the 90th percentile cut-of point in a
younger cohort [27]. Independent of Framingham Risk
Score (FRS), a CAC scan can improve assessment of risk
of coronary events in subjects with FRS <10% but not
Figure 1 FDRs cardiovascular risk as defined by Framingham Risk Score, presence of subclinical atherosclerosis in either carotid or
coronary arteries and negative calcium scoring scan*.
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study, significant association between family history of
myocardial infarction and CAC was shown in younger
(men <45, women <55) but not in older subjects [29].
Similar to previous studies, our results indicate that in
middle-aged (39–55 years) asymptomatic FDRs the inci-
dence of positive CAC findings is double that of con-
trols [26].
Terry et al. showed CAC (AUC 0.91) to be superior to
IMT (AUC 0.73) as a predictor of angiographic CAD,
findings suggested by Sesse et al. a decade earlier
[30,31]. Recently, in the largest prospective study to
compare CAC and IMT ability to predict CVD events in
asymptomatic subjects, Folsom demonstrated that CAC
is a better predictor of CHD while maximal IMT is a
modestly better predictor of stroke [32]. In our unique
cohort, the presence of family history was associated
with a high odds ratio for detection of subclinical ath-
erosclerosis using either CAC scan or IMT [17]. When
the 75th percentile cut off is used, the CAC odds ratios
are higher for men than for women. Furthermore, we
have found that all subjects with family history of early
CAD, where atherosclerosis had been identified by a
positive CAC scan, also had an increased IMT or pla-
ques by carotid ultrasound.
Taylor et al., in a prospective 4-year follow up study,
demonstrated a significant and independent relation be-
tween carotid non-calcified atherosclerosis and progres-
sion of CAC. [16,33]. Our study demonstrated strong
correlations between carotid ultrasound indexes and
CAC score. Both CAC scoring and carotid ultrasound
scans are used to evaluate burden of subclinical athero-
sclerosis, therefore a degree of overlap in their findings
is to be expected. We’ve shown, however, that the over-
lap or agreement between the two methods for the de-
tection of the presence of atherosclerosis in individual
patients is modest, with a kappa coefficient of agreement
between 0.2 and 0.3 on a 0 to 1 scale.In practice, an Agatston score above 100 is considered
to be highly predictive for CAD [34]. In our study, all 10
FDRs with an Agatston score over 100 had plaques
detected at carotid ultrasound scan. However, not all
subjects with carotid plaques alone or plaques and
increased IMT, had positive CAC findings. Moreover, 22
FDRs with detectable carotid plaques, 13 of which had
at least one or more cardiovascular risk factors (high
blood pressure, dyslipidemia or smoking), had CAC
score of 0. The fact that more FDRs had a CAC of zero
compared with controls (64.9% vs. 50.1%) can be
explained by the 10 years difference in average age be-
tween the cohorts. Thus, absolute scores like 0 and 100
which are not adjustable for age and sex were less useful
for defining positive or negative findings than the 75th
percentile we’ve used.
While our study provides a unique look at asymptom-
atic FDRs of patients with early onset of angiographically
documented CAD, and also compares CAC findings to
ultrasound indexes that assess both IMT and plaque bur-
den, there are several study limitations.
A number of differences between the study cohort and
control population both in regards to data collected and
demographics are present. As the control group was
obtained retrospectively from a large set of patients hav-
ing clinically indicated CAC scans, no CIMT data or
blood work was obtained from the controls. As such,
comment with regards to the nature of the CIMT data,
outside of the correlation on a per patient basis in the
FDR cohort, is limited. The same would hold true for
the laboratory data (CRP etc.)The cohort is of predomin-
antly of European ethnic background and thus the
results may not be applicable to non-Caucasian popula-
tions. Additionally, there are significant age and sex dif-
ferences between the FDR and control cohorts. While
we have no information on other cardiovascular risk fac-
tors in the controls, the fact that they were refered for
the scan suggests a clinical suspicion for CHD, most
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factor. This may explain the higher frequency of 0 CAC
scores in FDRs and could have diminished the difference
we noted in positive CAC findings between cohorts. It is
well established that age and sex play a significant role
in development of coronary artery calcium. While it
would be inappropriate, based on the cohort differences,
to directly compare raw Agatston or volume scores, it is
felt that adjustment for age and sex, utilizing a percentile
cutoff (75% in our study), as was done with the MESA
data, helps to avoid this problem. Furthermore, a mix-
ture of 8-and 64-slice MDCT scans were used in the
control group. While an accepted source of error, large
multicenter trials have demonstrated only negligible (less
than 4%) differences between these two methods for
assessing CAC [35]. As mentioned in the methods sec-
tion, a lag time of up to one year between CIMT acquisi-
tion and CAC assessment may be present in select
patients. Although in this setting we cannot entirely ex-
clude progression of CAC values in this timeframe data
from Min JK et al. determined progression of CAC to be
a fairly slow process [36].
Future directions
The initial presentation of up to 25% of patients present-
ing with CAD will be sudden death or unstable angina.
Identifying the “at risk patient” has lead to an increased
interest in adding imaging correlates to help guide risk
stratification and ultimately risk factor modification.
Carotid ultrasound measures of plaque, CIMT and
CAC have emerged as powerful tools to help accomplish
this goal. Further data elucidating the relationship of
CIMT and CAC in patients with a family history of early
onset coronary disease are necessary.
Multiple studies have demonstrated a 10 year CV
event rate close to 1% for subjects with zero Agatston
score, thus such subjects should belong to the low risk
category [12,37,38]. However, there is evidence that up
to 10% of subjects with a zero CAC score can have clin-
ically significant, minimally or non-calcified coronary
plaques [39]. While in FDRs carotid ultrasound can
identify all subjects with subclinical atherosclerosis, a
CAC score of 0 may identify many FDRs who, despite
some evidence of atherosclerosis based on carotid scan-
ning, may actually have a low cardiovascular risk (see
Figure 1), though this has not specifically been shown to
be the case in any prospective studies. Moreover, the
temporal evolution of carotid abnormalities and positive
CAC findings may well be different, with the later re-
quiring longer duration of disease.
In this patient population we have demonstrated that
many patients with a CAC of 0 will have positive CIMT
findings. However we have no control data to determine
whether in a matched population this finding isconstant. Whether those patients with a CAC of 0 but
positive carotid ultrasound data represent a group that
deserves more aggressive risk factor modification is not
known.
Clinical trials investigating the validity of such ap-
proach in practice are warranted and given the differ-
ences in sensitivity for detection of disease between the
two techniques noted in this unique cohort, such trials
are especially warranted in FDRs.
Conclusions
Asymptomatic FDRs have a two-fold increase in the
likelihood of positive findings of CAC scoring compared
to controls. CAC scores correlate highly with carotid
ultrasound indexes of early atherosclerosis, but in indi-
vidual patients, disparate results may be seen, Both
methods provide additional information that is generally
accepted to help clarify the risk of future CV events.
Studies of the optimal use of these methods, especially
in asymptomatic FDRs is warranted particularly in those
perceived to be at intermediate risk based on currently
used risk prediction algorithms that do not take into ac-
count findings from imaging studies.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
CT participated in the collection and analysis of data and writing of the
manuscript. CH participated in the data collection and writing of the
manuscript. BF and JBM participated in conception of the study, supervision,
data analysis and manuscript editing. JF participated in conception and
oversight of the study, supervision, data analysis and manuscript preparation.
All authors read and approved the final manuscript.
Acknowledgements
This project was partially supported by an unrestricted research grant form
the Pfizer Canada Inc. and conducted at the Providence Healthcare Research
Institute, Healthy Heart Program at St. Paul Hospital, Department of
Pathology and Laboratory medicine, Faculty of Medicine, University of British
Columbia. The authors want to thank Canada Diagnostic Canter staff
members who helped coordinate these scans.
Author details
1Department of Pathology and Laboratory medicine, Faculty of Medicine,
University of British Columbia, Vancouver, BC, Canada. 2Department of
Radiology, Faculty of Medicine, University of British Columbia, Vancouver, BC,
Canada. 3Healthy Heart Prevention Clinic, Providence Heart and Lung
Institute, St. Paul Hospital, Vancouver, BC, Canada. 4Department of Medicine,
Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
Received: 15 February 2012 Accepted: 28 June 2012
Published: 17 July 2012
References
1. Barrett-Connor E, Khaw K: Family history of heart attack as an
independent predictor of death due to cardiovascular disease. Circulation
1984, 69(6):1065–1069.
2. Shea SOR, Gabrieli C, Stein Z, Nichols A: Family history as an independent
risk factor for coronary artery disease. J Am Coll Cardiol 1984, 4:793–801.
3. Friedlander Y, Kark JD, Stein Y: Family history of myocardial infarction as
an independent risk factor for coronary heart disease. Br Heart J 1985,
53(4):382–387.
Taraboanta et al. BMC Cardiovascular Disorders 2012, 12:53 Page 7 of 7
http://www.biomedcentral.com/1471-2261/12/534. Hopkins PN, Williams RR, Kuida H, Stults BM, Hunt SC, Barlow GK, et al:
Family history as an independent risk factor for incident coronary artery
disease in a high-risk cohort in Utah. Am J of Cardiol 1988,
62(10 Pt 1):703–707.
5. Andresdottir MB, Sigurdsson G, Sigvaldason H, Gudnason V: Fifteen percent
of myocardial infarctions and coronary revascularizations explained by
family history unrelated to conventional risk factors. The Reykjavik
Cohort Study. Eur Heart J 2002, 23(21):1655–1663.
6. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM,
et al: General cardiovascular risk profile for use in primary care: the
Framingham Heart Study. Circulation 2008, 117(6):743–753.
7. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R,
Dallongeville J, et al: European guidelines on cardiovascular disease
prevention in clinical practice. Third Joint Task Force of European and
Other Societies on Cardiovascular Disease Prevention in Clinical Practice.
Eur Heart J 2003, 24(17):1601–1610.
8. Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, et al: AHA/
ACC guidelines for secondary prevention for patients with coronary and
other atherosclerotic vascular disease: 2006 update: endorsed by the
National Heart, Lung, and Blood Institute. Circulation 2006,
113(19):2363–2372.
9. Genest J, McPherson R, Frohlich J, Anderson T, Campbell N, Carpentier A,
et al: 2009 Canadian Cardiovascular Society/Canadian guidelines for the
diagnosis and treatment of dyslipidemia and prevention of
cardiovascular disease in the adult - 2009 recommendations. The
Canadian journal of cardiology 2009, 25(10):567–579.
10. Blankenhorn DH: Calcification of the coronary arteries. Am J Roentgenol
Radium Ther Nucl Med 1959, 81(5):772–777.
11. Shaw LJ, Raggi P, Schisterman E, Berman DS, Callister TQ: Prognostic value
of cardiac risk factors and coronary artery calcium screening for all-
cause mortality. Radiology 2003, 228(3):826–833.
12. Arad Y, Goodman KJ, Roth M, Newstein D, Guerci AD: Coronary
calcification, coronary disease risk factors, C-reactive protein, and
atherosclerotic cardiovascular disease events: the St. Francis Heart Study.
J Am Coll Cardiol 2005, 46(1):158–165.
13. Budoff MJ, Shaw LJ, Liu ST, Weinstein SR, Mosler TP, Tseng PH, et al: Long-
term prognosis associated with coronary calcification: observations from
a registry of 25,253 patients. J Am Coll Cardiol 2007, 49(18):1860–1870.
Epub 2007 Apr 20.
14. LaMonte MJ, Fitzgerald SJ, Levine BD, Church TS, Kampert JB, Nichaman MZ,
et al: Coronary artery calcium, exercise tolerance, and CHD events in
asymptomatic men. Atherosclerosis 2006, 189(1):157–162. Epub 2006 Jan 24.
15. O'Rourke RA, Brundage BH, Froelicher VF, Greenland P, Grundy SM,
Hachamovitch R, et al: American College of Cardiology/American Heart
Association Expert Consensus document on electron-beam computed
tomography for the diagnosis and prognosis of coronary artery disease.
Circulation 2000, 102(1):126–140.
16. Taylor AJ, Bindeman J, Feuerstein I, Cao F, Brazaitis M, O'Malley PG:
Coronary calcium independently predicts incident premature coronary
heart disease over measured cardiovascular risk factors: mean three-year
outcomes in the Prospective Army Coronary Calcium (PACC) project.
J Am Coll Cardiol 2005, 46(5):807–814.
17. Taraboanta C, Wu E, Lear S, DiPalma S, Hill J, Mancini GB, et al: Subclinical
atherosclerosis in subjects with family history of premature coronary
artery disease. Am Heart J 2008, 155(6):1020–1026. e1.
18. Aminbakhsh A, Frohlich J, Mancini GB: Detection of early atherosclerosis
with B mode carotid ultrasonography: assessment of a new quantitative
approach. Clin Invest Med 1999, 22(6):265–274.
19. Mancini GB, Abbott D, Kamimura C, Yeoh E: Validation of a new
ultrasound method for the measurement of carotid artery intima medial
thickness and plaque dimensions. Can J Cardiol 2004, 20(13):1355–1359.
20. Hausleiter J, Meyer T, Hadamitzky M, Huber E, Zankl M, Martinoff S, et al:
Radiation dose estimates from cardiac multislice computed tomography
in daily practice: impact of different scanning protocols on effective
dose estimates. Circulation 2006, 113(10):1305–1310. Epub 2006 Mar 6.
21. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano
R: Quantification of coronary artery calcium using ultrafast computed
tomography. J Am Coll Cardiol 1990, 15(4):827–832.
22. Callister TQ, Cooil B, Raya SP, Lippolis NJ, Russo DJ, Raggi P: Coronary artery
disease: improved reproducibility of calcium scoring with an electron-
beam CT volumetric method. Radiology 1998, 208(3):807–814.23. Budoff MJ: Atherosclerosis imaging and calcified plaque: coronary artery
disease risk assessment. Prog Cardiovasc 2003, 46(2):135–148.
24. Hoff JA, Chomka EV, Krainik AJ, Daviglus M, Rich S, Kondos GT: Age and
gender distributions of coronary artery calcium detected by electron
beam tomography in 35,246 adults. Am J Cardiol 2001, 87(12):1335–1339.
25. Altman D: Practical Statistics for Medical Research. London: Chapman &Hall;
1991.
26. Nasir K, Budoff MJ, Wong ND, Scheuner M, Herrington D, Arnett DK, et al:
Family history of premature coronary heart disease and coronary artery
calcification: Multi-Ethnic Study of Atherosclerosis (MESA). Circulation
2007, 116(6):619–626.
27. Parikh NI, Hwang SJ, Larson MG, Cupples LA, Fox CS, Manders ES, et al:
Parental occurrence of premature cardiovascular disease predicts
increased coronary artery and abdominal aortic calcification in the
Framingham Offspring and Third Generation cohorts. Circulation 2007,
116(13):1473–1481. Epub 2007 Sep 4.
28. Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC: Coronary artery
calcium score combined with Framingham score for risk prediction in
asymptomatic individuals. JAMA 2004, 291(2):210–215.
29. Philips B, de Lemos JA, Patel MJ, McGuire DK, Khera A: Relation of family
history of myocardial infarction and the presence of coronary arterial
calcium in various age and risk factor groups. Am J Cardiol 2007,
99(6):825–829. Epub 2007 Jan 30.
30. Seese B, Brandt-Pohlmann M, Moshage W, Achenbach S, Schwarz T,
Bachmann K: Evaluation of the Association Between Coronary
Calcification Detected by Electron Beam Computed Tomography and
Atherosclerosis of Extracranial Carotid Arteries In Vivo. Int J Angiol 1998,
7(4):301–306.
31. Terry JG, Carr JJ, Tang R, Evans GW, Kouba EO, Shi R, et al: Coronary artery
calcium outperforms carotid artery intima-media thickness as a
noninvasive index of prevalent coronary artery stenosis. Arterioscler
Thromb Vasc Biol 2005, 25(8):1723–1728. Epub 2005 Jun 9.
32. Folsom AR, Kronmal RA, Detrano RC, O'Leary DH, Bild DE, Bluemke DA, et al:
Coronary artery calcification compared with carotid intima-media
thickness in the prediction of cardiovascular disease incidence: the
Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med 2008,
168(12):1333–1339.
33. Taylor AJ, Bindeman J, Le TP, Bauer K, Byrd C, Feuerstein IM, et al:
Progression of calcified coronary atherosclerosis: Relationship to
coronary risk factors and carotid intima-media thickness. Atherosclerosis
2007, 27:27.
34. Arad Y, Spadaro LA, Goodman K, Lledo-Perez A, Sherman S, Lerner G, et al:
Predictive value of electron beam computed tomography of the
coronary arteries. 19-month follow-up of 1173 asymptomatic subjects.
Circulation 1996, 93(11):1951–1953.
35. McClelland RL, Chung H, Detrano R, Post W, Kronmal RA: Distribution of
coronary artery calcium by race, gender, and age: results from the Multi-
Ethnic Study of Atherosclerosis (MESA). Circulation 2006, 113(1):30–37.
Epub 2005 Dec 19.
36. Min JK, Shaw LJ, Berman DS: The present state of coronary computed
tomography angiography a process in evolution. J Am Coll Cardiol 2010,
55(10):957–965.
37. Becker ALA, Becker C, Knez A: Predictive value of coronary calcifications
for future cardiac events in asymptomatic individuals. Am Heart J 2008,
155(1):154–160. Epub 2007 Oct 17.
38. Blaha MBM, Shaw LJ, Khosa F, Rumberger JA, Berman D, Callister T, Raggi P,
Blumenthal RS, Nasir K: Absence of coronary artery calcification and all-
cause mortality. JACC Cardiovasc Imaging 2009, 2(6):692–700.
39. Sarwar A, Shaw L, Shapiro M, Blankstein R, Hoffman U, Cury R, et al:
Diagnostic and prognostic value of absence of coronary artery
calcification. JACC Cardiovasc Imaging 2009, 2(6):675–688.
doi:10.1186/1471-2261-12-53
Cite this article as: Taraboanta et al.: Coronary artery calcium findings in
asymptomatic subjects with family history of premature coronary artery
disease. BMC Cardiovascular Disorders 2012 12:53.
